CARE Reaffirms Dhampur Bio Organics Ratings; Outlook Revised to Positive
Dhampur Bio Organics Ltd · Others (Uncategorized) · 05 Sept 2026, 6:15 pm
CARE Reaffirms Dhampur Bio Organics Ratings; Outlook Revised to Positive CARE Ratings reaffirmed Dhampur Bio Organics' long-term bank facilities at CARE BBB+ and short-term facilities at CARE A2, revising the long-term outlook from Stable to Positive. The outlook revision reflects an improving financial risk profile driven by debt reduction from proceeds of the Meerganj unit slump sale for ₹305 crore in Jun'26. Long-term debt declined to ₹125 crore as of 31st Jul'26 from ₹290 crore on 31st Mar'26. Consequently, net leverage is projected to drop below 5.5x by FY27-end, supported by firm sugar prices.
Original exchange filing (PDF)
More announcements from Dhampur Bio Organics Ltd
- Please find attached the Investor Presentation for the Quarter ended September 30, 2026. · 15 Nov 2026
- Appointment of Cost Auditor of the Company to fill casual vacancy for the FY 2026-27. · 14 Nov 2026
- Audited Financial Results for the quarter and half year ended September 30, 2026 · 14 Nov 2026
- Dhampur Bio Organics Limited has submitted to the Exchange, the audited financial results for the period ended September 30, 2026 and approved the buyback subject to the approval of shareholders. · 14 Nov 2026
- Outcome of Board Meeting held on November 14, 2026 · 14 Nov 2026
- Intimation of Grant of Stock options pursuant to DBO Employee Stock Option Scheme 2025 as approved by the Nomination and Remuneration Committee. · 12 Nov 2026
- Dhampur Bio Organics Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to consider and approve the Quarterly Audited Financial results of the Company for the period ended September 2026 and Buyback/Other business. · 14 Nov 2026
- Dhampur Bio Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve 1. Audited Standalone .... · 14 Nov 2026
